Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
KIM-1–mediated phagocytosis reduces acute injury to the kidney
Li Yang, … , Vijay Kuchroo, Joseph V. Bonventre
Li Yang, … , Vijay Kuchroo, Joseph V. Bonventre
Published March 9, 2015
Citation Information: J Clin Invest. 2015;125(4):1620-1636. https://doi.org/10.1172/JCI75417.
View: Text | PDF
Research Article Nephrology

KIM-1–mediated phagocytosis reduces acute injury to the kidney

  • Text
  • PDF
Abstract

Kidney injury molecule 1 (KIM-1, also known as TIM-1) is markedly upregulated in the proximal tubule after injury and is maladaptive when chronically expressed. Here, we determined that early in the injury process, however, KIM-1 expression is antiinflammatory due to its mediation of phagocytic processes in tubule cells. Using various models of acute kidney injury (AKI) and mice expressing mutant forms of KIM-1, we demonstrated a mucin domain–dependent protective effect of epithelial KIM-1 expression that involves downregulation of innate immunity. Deletion of the mucin domain markedly impaired KIM-1–mediated phagocytic function, resulting in increased proinflammatory cytokine production, decreased antiinflammatory growth factor secretion by proximal epithelial cells, and a subsequent increase in tissue macrophages. Mice expressing KIM-1Δmucin had greater functional impairment, inflammatory responses, and mortality in response to ischemia- and cisplatin-induced AKI. Compared with primary renal proximal tubule cells isolated from KIM-1Δmucin mice, those from WT mice had reduced proinflammatory cytokine secretion and impaired macrophage activation. The antiinflammatory effect of KIM-1 expression was due to the interaction of KIM-1 with p85 and subsequent PI3K-dependent downmodulation of NF-κB. Hence, KIM-1–mediated epithelial cell phagocytosis of apoptotic cells protects the kidney after acute injury by downregulating innate immunity and inflammation.

Authors

Li Yang, Craig R. Brooks, Sheng Xiao, Venkata Sabbisetti, Melissa Y. Yeung, Li-Li Hsiao, Takaharu Ichimura, Vijay Kuchroo, Joseph V. Bonventre

×

Figure 7

Expression of WT KIM-1, but not KIM-1Δmucin, in kidney epithelial cells downregulates the activation of macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Expression of WT KIM-1, but not KIM-1Δmucin, in kidney epithelial cells ...
(A) TNF-α secretion by BMMs exposed to conditioned media (CM) collected from LLC-PK1 cells expressing pCDH, WT KIM-1, or KIM-1Δmucin incubated with apoptotic cells or not and then treated with TNF-α or LPS without apoptotic cells before incubation (n = 5). *P < 0.01; #P < 0.05. (B) Percentage of BrdU+ BMMs after a 24-hour treatment with conditioned media from LLC-PK1 cells expressing pCDH vector, WT KIM-1, or KIM-1Δmucin (n = 3). *P < 0.05. (C) Relationship between WT KIM-1 expression in LLC-PK1 cells and TNF-α secretion by BMMs treated with conditioned media from these cells. The control was set as the LLC-PK1 group that had the highest level of KIM-1 expression or the BMM group that had the highest TNF-α secretion levels. The conditioned media from LLC-PK1 cells expressing KIM-1 had a dose-dependent effect on the decrease in TNF-α secretion by BMMs (n = 3). r = 0.916; P = 0.04. Groups were compared by ANOVA followed by Bonferroni’s post-hoc analysis (A and B) and Spearman’s rank correlation test (C). CM, conditioned media.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts